A citation-based method for searching scientific literature

L Chaillous, H Lefèvre, C Thivolet, C Boitard, N Lahlou, C Atlan-Gepner, B Bouhanick, A Mogenet, M Nicolino, J C Carel, P Lecomte, R Maréchaud, P Bougnères, B Charbonnel, P Saï. Lancet 2000
Times Cited: 177







List of co-cited articles
1404 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.
P Pozzilli, D Pitocco, N Visalli, M G Cavallo, R Buzzetti, A Crinò, S Spera, C Suraci, G Multari, M Cervoni,[...]. Diabetologia 2000
146
60

Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.
Jay S Skyler, Jeffrey P Krischer, Joseph Wolfsdorf, Catherine Cowie, Jerry P Palmer, Carla Greenbaum, David Cuthbertson, Lisa E Rafkin-Mervis, H Peter Chase, Ellen Leschek. Diabetes Care 2005
385
50


Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial.
Kirsti Näntö-Salonen, Antti Kupila, Satu Simell, Heli Siljander, Tiina Salonsaari, Anne Hekkala, Sari Korhonen, Risto Erkkola, Jukka I Sipilä, Lotta Haavisto,[...]. Lancet 2008
241
42

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.
Bart Keymeulen, Evy Vandemeulebroucke, Anette G Ziegler, Chantal Mathieu, Leonard Kaufman, Geoff Hale, Frans Gorus, Michel Goldman, Markus Walter, Sophie Candon,[...]. N Engl J Med 2005
785
41

GAD treatment and insulin secretion in recent-onset type 1 diabetes.
Johnny Ludvigsson, Maria Faresjö, Maria Hjorth, Stina Axelsson, Mikael Chéramy, Mikael Pihl, Outi Vaarala, Gun Forsander, Sten Ivarsson, Calle Johansson,[...]. N Engl J Med 2008
332
40

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus.
Kevan C Herold, William Hagopian, Julie A Auger, Ena Poumian-Ruiz, Lesley Taylor, David Donaldson, Stephen E Gitelman, David M Harlan, Danlin Xu, Robert A Zivin,[...]. N Engl J Med 2002
837
36

Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.
Mark D Pescovitz, Carla J Greenbaum, Heidi Krause-Steinrauf, Dorothy J Becker, Stephen E Gitelman, Robin Goland, Peter A Gottlieb, Jennifer B Marks, Paula F McGee, Antoinette M Moran,[...]. N Engl J Med 2009
629
36

Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.
Z J Zhang, L Davidson, G Eisenbarth, H L Weiner. Proc Natl Acad Sci U S A 1991
534
31

Oral insulin therapy to prevent progression of immune-mediated (type 1) diabetes.
Berrin Ergun-Longmire, John Marker, Adina Zeidler, Robert Rapaport, Philip Raskin, Bruce Bode, Desmond Schatz, Alfonso Vargas, Douglas Rogers, Sherwyn Schwartz,[...]. Ann N Y Acad Sci 2004
46
65

Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.
Maki Nakayama, Norio Abiru, Hiroaki Moriyama, Naru Babaya, Edwin Liu, Dongmei Miao, Liping Yu, Dale R Wegmann, John C Hutton, John F Elliott,[...]. Nature 2005
523
30

Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes.
Leonard C Harrison, Margo C Honeyman, Cheryl E Steele, Natalie L Stone, Elena Sarugeri, Ezio Bonifacio, Jennifer J Couper, Peter G Colman. Diabetes Care 2004
131
29

A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes.
Kevan C Herold, Stephen E Gitelman, Umesh Masharani, William Hagopian, Brygida Bisikirska, David Donaldson, Kristina Rother, Beverly Diamond, David M Harlan, Jeffrey A Bluestone. Diabetes 2005
459
28


No effect of the altered peptide ligand NBI-6024 on beta-cell residual function and insulin needs in new-onset type 1 diabetes.
Markus Walter, Areti Philotheou, François Bonnici, Anette-G Ziegler, Roland Jimenez. Diabetes Care 2009
79
32

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.
Diane K Wherrett, Brian Bundy, Dorothy J Becker, Linda A DiMeglio, Stephen E Gitelman, Robin Goland, Peter A Gottlieb, Carla J Greenbaum, Kevan C Herold, Jennifer B Marks,[...]. Lancet 2011
226
26

GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.
Johnny Ludvigsson, David Krisky, Rosaura Casas, Tadej Battelino, Luis Castaño, James Greening, Olga Kordonouri, Timo Otonkoski, Paolo Pozzilli, Jean-Jacques Robert,[...]. N Engl J Med 2012
188
25

Aerosol insulin induces regulatory CD8 gamma delta T cells that prevent murine insulin-dependent diabetes.
L C Harrison, M Dempsey-Collier, D R Kramer, K Takahashi. J Exp Med 1996
266
24

Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.
L Chatenoud, E Thervet, J Primo, J F Bach. Proc Natl Acad Sci U S A 1994
499
23

Evidence that nasal insulin induces immune tolerance to insulin in adults with autoimmune diabetes.
Spiros Fourlanos, Christine Perry, Shane A Gellert, Emanuela Martinuzzi, Roberto Mallone, Jeanne Butler, Peter G Colman, Leonard C Harrison. Diabetes 2011
79
29

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.
Tihamer Orban, Brian Bundy, Dorothy J Becker, Linda A DiMeglio, Stephen E Gitelman, Robin Goland, Peter A Gottlieb, Carla J Greenbaum, Jennifer B Marks, Roshanak Monzavi,[...]. Lancet 2011
347
23

Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes.
Carl-David Agardh, Corrado M Cilio, AsaLinda Lethagen, Kristian Lynch, R David G Leslie, Mats Palmér, Robert A Harris, John A Robertson, Ake Lernmark. J Diabetes Complications 2005
149
22

Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy.
Tihamer Orban, Klara Farkas, Heyam Jalahej, Janos Kis, Andras Treszl, Ben Falk, Helena Reijonen, Joseph Wolfsdorf, Alyne Ricker, Jeffrey B Matthews,[...]. J Autoimmun 2010
79
26


Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health.
Sefina Arif, Timothy I Tree, Thomas P Astill, Jennifer M Tremble, Amanda J Bishop, Colin M Dayan, Bart O Roep, Mark Peakman. J Clin Invest 2004
363
19

Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice.
Chang-yun Hu, Daniel Rodriguez-Pinto, Wei Du, Anupama Ahuja, Octavian Henegariu, F Susan Wong, Mark J Shlomchik, Li Wen. J Clin Invest 2007
295
19


Effect of heat shock protein peptide DiaPep277 on beta-cell function in paediatric and adult patients with recent-onset diabetes mellitus type 1: two prospective, randomized, double-blind phase II trials.
Nanette C Schloot, Guido Meierhoff, Csaba Lengyel, Gyözö Vándorfi, József Takács, Pál Pánczél, László Barkai, László Madácsy, Tamás Oroszlán, Peter Kovács,[...]. Diabetes Metab Res Rev 2007
78
23

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial.
Nicole Sherry, William Hagopian, Johnny Ludvigsson, Sunil M Jain, Jack Wahlen, Robert J Ferry, Bruce Bode, Stephen Aronoff, Christopher Holland, David Carlin,[...]. Lancet 2011
290
18

Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs.
Damien Bresson, Lisa Togher, Evelyn Rodrigo, Yali Chen, Jeffrey A Bluestone, Kevan C Herold, Matthias von Herrath. J Clin Invest 2006
234
17

A comprehensive review of interventions in the NOD mouse and implications for translation.
Lisl K M Shoda, Daniel L Young, Saroja Ramanujan, Chan C Whiting, Mark A Atkinson, Jeffrey A Bluestone, George S Eisenbarth, Diane Mathis, Aldo A Rossini, Scott E Campbell,[...]. Immunity 2005
224
17

Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass.
B Keymeulen, M Walter, C Mathieu, L Kaufman, F Gorus, R Hilbrands, E Vandemeulebroucke, U Van de Velde, L Crenier, C De Block,[...]. Diabetologia 2010
211
17

C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.
Carlos E B Couri, Maria C B Oliveira, Ana B P L Stracieri, Daniela A Moraes, Fabiano Pieroni, George M N Barros, Maria Isabel A Madeira, Kelen C R Malmegrim, Maria C Foss-Freitas, Belinda P Simões,[...]. JAMA 2009
266
17

Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice.
J Tian, M Clare-Salzler, A Herschenfeld, B Middleton, D Newman, R Mueller, S Arita, C Evans, M A Atkinson, Y Mullen,[...]. Nat Med 1996
223
16

Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.
D L Kaufman, M Clare-Salzler, J Tian, T Forsthuber, G S Ting, P Robinson, M A Atkinson, E E Sercarz, A J Tobin, P V Lehmann. Nature 1993
16

Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.
Júlio C Voltarelli, Carlos E B Couri, Ana B P L Stracieri, Maria C Oliveira, Daniela A Moraes, Fabiano Pieroni, Marina Coutinho, Kelen C R Malmegrim, Maria C Foss-Freitas, Belinda P Simões,[...]. JAMA 2007
354
16

Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset.
C R Stiller, J Dupré, M Gent, M R Jenner, P A Keown, A Laupacis, R Martell, N W Rodger, B von Graffenried, B M Wolfe. Science 1984
625
16

Etanercept treatment in children with new-onset type 1 diabetes: pilot randomized, placebo-controlled, double-blind study.
Lucy Mastrandrea, Jihnhee Yu, Torsten Behrens, John Buchlis, Christine Albini, Shannon Fourtner, Teresa Quattrin. Diabetes Care 2009
143
16

Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis.
H L Weiner, G A Mackin, M Matsui, E J Orav, S J Khoury, D M Dawson, D A Hafler. Science 1993
544
15

Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.
R Tisch, X D Yang, S M Singer, R S Liblau, L Fugger, H O McDevitt. Nature 1993
923
15

The NOD mouse: a model of immune dysregulation.
Mark S Anderson, Jeffrey A Bluestone. Annu Rev Immunol 2005
756
15

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes.
J Tian, M A Atkinson, M Clare-Salzler, A Herschenfeld, T Forsthuber, P V Lehmann, D L Kaufman. J Exp Med 1996
378
15

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes.
Qizhi Tang, Kammi J Henriksen, Mingying Bi, Erik B Finger, Greg Szot, Jianqin Ye, Emma L Masteller, Hugh McDevitt, Mark Bonyhadi, Jeffrey A Bluestone. J Exp Med 2004
876
15

Heat-shock protein peptide DiaPep277 treatment in children with newly diagnosed type 1 diabetes: a randomised, double-blind phase II study.
L Lazar, R Ofan, N Weintrob, A Avron, M Tamir, D Elias, M Phillip, Z Josefsberg. Diabetes Metab Res Rev 2007
73
20


TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes.
Mériam Belghith, Jeffrey A Bluestone, Samia Barriot, Jérôme Mégret, Jean-François Bach, Lucienne Chatenoud. Nat Med 2003
478
14

Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.
Balasubramanian Krishnamurthy, Nadine L Dudek, Mark D McKenzie, Anthony W Purcell, Andrew G Brooks, Shane Gellert, Peter G Colman, Leonard C Harrison, Andrew M Lew, Helen E Thomas,[...]. J Clin Invest 2006
167
14

Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes.
L Yu, D T Robles, N Abiru, P Kaur, M Rewers, K Kelemen, G S Eisenbarth. Proc Natl Acad Sci U S A 2000
353
14

Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study.
S L Thrower, L James, W Hall, K M Green, S Arif, J S Allen, C Van-Krinks, B Lozanoska-Ochser, L Marquesini, S Brown,[...]. Clin Exp Immunol 2009
105
14



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.